• Aucun résultat trouvé

Minimisation of bleeding risks due to direct oral anticoagulants

N/A
N/A
Info
Télécharger
Protected

Academic year: 2021

Partager "Minimisation of bleeding risks due to direct oral anticoagulants"

Copied!
14
0
0

Chargement.... (Voir le texte intégral maintenant)

Texte intégral

Figure

Table 1: Summary of pharmacokinetic properties, indication, and dose regimens of direct oral anticoagulants in the European Union
Table 1 continued.
Table 2: Summary of drug-drug interactions with available recommendations for dose adaptation or contraindications by the competent authorities
Table 2 continued. Dabigatran P-gp substrate RivaroxabanP-gp and CYP3A4/2J2 substrate Apixaban P-gp and CYP3A4/5 substrate Edoxaban P-gp substrate Molecule Mechanism Diltiazem P-gp and
+4

Références

Télécharger maintenant ( PDF - 14 Page - 536.00 KB )

Documents relatifs

Direct oral anticoagulants: a guide for daily practice

As of today, these direct oral anticoagulants (DOACs) include dabigatran etexilate (thrombin inhibitor) and apixaban, edoxaban and rivaroxaban (inhibitors of FXa).. While there is

Weight Age SQ Kg BP Kg DL Kg Total Kg

Melissa Tew, Audrey Copeland, Johah Lewis, Julian Onuoha, Brandon Balance, Charles Walton, Ryan King and Christi Galloway Johnny & Mindy Layne. Johnny &

Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry

Baseline characteristics (demographic, clinical, risk factors) of patients, laboratory data at admission and during follow-up, site of bleeding, therapeutic strategies, and outcomes

30% au lieu de / kg. ORANGES PORTUGAL / kg

Plus d’informations sur la collecte de points sur manor.ch/fidelite ** Toutes les offres de spiritueux présentées ici ne sont pas soumises à la durée de validité de

Direct oral anticoagulants and digestive bleeding: therapeutic management and preventive measures

In the management of deep vein thrombosis (DVT) and pulmonary embolism (PE), six rand- omized controlled trials have been conducted with 26,997 patients and have shown that DOACs

NLA51A/ Straßäcker 2 D Untersiemau max. 30 Kg

Procúrese el mater al adecuado para la fijac ón a la pared!. Zakup odpow edn mater ał do przymocowan a na śc

Edoxaban for the Long-Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

14,15 According to the product label, the recommended dose of edoxaban for long-term therapy is 60  mg daily, but this dose should be reduced to 30 mg daily in patients

Argomentare per superare il conflitto : l'argomentazione nella mediazione

Se l’attenzione alla ricostruzione della storia del conflitto mostra, da un lato, l’importanza che si attribuisce all’identificazione della sua origine,